MGMT promoter methylation and hypermutant recurrence in IDH mutant lower-grade glioma

被引:6
|
作者
Miller, Julie J. [1 ,2 ]
Cahill, Daniel P. [1 ,3 ]
机构
[1] Harvard Med Sch, Massachusetts Gen Hosp, Translat Neurooncol Lab, Boston, MA 02115 USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Div Neurooncol, Dept Neurol, Boston, MA 02115 USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02115 USA
关键词
glioma; IDH1; mutation; temozolomide; TEMOZOLOMIDE; PROCARBAZINE; VINCRISTINE; PROGRESSION; LOMUSTINE; EVOLUTION; THERAPY; BENEFIT;
D O I
10.1093/neuonc/noaa212
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1553 / 1554
页数:2
相关论文
共 50 条
  • [41] 'The Reports of My Death Are Greatly Exaggerated'-Evaluating the Effect of Necrosis on MGMT Promoter Methylation Testing in High-Grade Glioma
    Satgunaseelan, Laveniya
    Lee, Maggie
    Iannuzzi, Sebastian
    Hallal, Susannah
    Deang, Kristine
    Stanceski, Kristian
    Wei, Heng
    Mason, Sofia
    Shivalingam, Brindha
    Sim, Hao-Wen
    Buckland, Michael E.
    Alexander, Kimberley L.
    CANCERS, 2024, 16 (10)
  • [42] The predictive value of partial MGMT promoter methylation for IDH-wild-type glioblastoma patients
    Torre, Matthew
    Wen, Patrick Y.
    Iorgulescu, J. Bryan
    NEURO-ONCOLOGY PRACTICE, 2023, 10 (02) : 126 - 131
  • [43] IDH mutations but not TERTp mutations are associated with seizures in lower-grade gliomas
    Duan, Wen-chao
    Wang, Li
    Li, Ke
    Wang, Wei-wei
    Zhan, Yun-bo
    Zhang, Feng-jiang
    Yu, Bin
    Bai, Ya-hui
    Wang, Yan-min
    Ji, Yu-chen
    Zhou, Jin-qiao
    Liu, Xian-zhi
    Zhang, Zhen-yu
    MEDICINE, 2018, 97 (50)
  • [44] Prognostic impact of PDGFRA gain/amplification and MGMT promoter methylation status in patients with IDH wild-type glioblastoma
    Higa, Nayuta
    Akahane, Toshiaki
    Yokoyama, Seiya
    Yonezawa, Hajime
    Uchida, Hiroyuki
    Takajo, Tomoko
    Otsuji, Ryosuke
    Hamada, Taiji
    Matsuo, Kei
    Kirishima, Mari
    Hata, Nobuhiro
    Hanaya, Ryosuke
    Tanimoto, Akihide
    Yoshimoto, Koji
    NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
  • [45] IDH1/2 Mutation and MGMT Promoter Methylation - the Relevant Survival Predictors in Czech Patients with Brain Gliomas
    Kramar, F.
    Minarik, M.
    Benesova, L.
    Halkova, T.
    Netuka, D.
    Bradac, O.
    Benes, V.
    FOLIA BIOLOGICA, 2016, 62 (05) : 194 - 202
  • [46] Prognostic Value of MGMT Promoter Methylation and TP53 Mutation in Glioblastomas Depends on IDH1 Mutation
    Wang, Kai
    Wang, Yin-Yan
    Ma, Jun
    Wang, Jiang-Fei
    Li, Shao-Wu
    Jiang, Tao
    Dai, Jian-Ping
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (24) : 10893 - 10898
  • [47] The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas
    Juratli, T. A.
    Kirsch, M.
    Geiger, K.
    Klink, B.
    Leipnitz, E.
    Pinzer, T.
    Soucek, S.
    Schrok, E.
    Schackert, G.
    Krex, D.
    JOURNAL OF NEURO-ONCOLOGY, 2012, 110 (03) : 325 - 333
  • [48] The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomas
    Kinslow, Connor J.
    Roy, Soumyajit
    Iwamoto, Fabio M.
    Brown, Paul D.
    Destephano, David M.
    Canoll, Peter D.
    Qureshi, Summer S.
    Gallito, Matthew
    Sisti, Michael B.
    Bruce, Jeffrey N.
    Horowitz, David P.
    Kachnic, Lisa A.
    Neugut, Alfred, I
    Yu, James B.
    Mehta, Minesh P.
    Cheng, Simon K.
    Wang, Tony J. C.
    NEURO-ONCOLOGY, 2024, 26 (10) : 1839 - 1849
  • [49] Molecular Subtype Classification in Lower-Grade Glioma with Accelerated DTI
    Aliotta, E.
    Nourzadeh, H.
    Batchala, P. P.
    Schiff, D.
    Lopes, M. B.
    Druzgal, J. T.
    Mukherjee, S.
    Patel, S. H.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2019, 40 (09) : 1458 - 1463
  • [50] Combining hyperintense FLAIR rim and radiological features in identifying IDH mutant 1p/19q non-codeleted lower-grade glioma
    Li, Mingxiao
    Ren, Xiaohui
    Chen, Xuzhu
    Wang, Jincheng
    Shen, Shaoping
    Jiang, Haihui
    Yang, Chuanwei
    Zhao, Xuzhe
    Zhu, Qinghui
    Cui, Yong
    Lin, Song
    EUROPEAN RADIOLOGY, 2022, 32 (06) : 3869 - 3879